Thermal Ablation Devices Market Size, Share, Growth, and Industry Analysis, By Type (Interstitial Probes, Grounded Probes, Needle Applications, Radiofrequency Ablation, Hydrothermal Ablation and Microwave Ablation), By Application (Hospitals, Ambulatory Surgical Centers (ASCs) and Clinics), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

THERMAL ABLATION DEVICES MARKET OVERVIEW

The global thermal ablation devices market size in 2025 is estimated to be USD 4.29 billion, with projections to grow to USD 9.95 billion by 2034 at a CAGR of 9.81% during the forecast period from 2025 to 2034.

The United States Thermal Ablation Devices market size is projected at USD 1.43 billion in 2025, the Europe Thermal Ablation Devices market size is projected at USD 1.14 billion in 2025, and the China Thermal Ablation Devices market size is projected at USD 1.09 billion in 2025.

The thermal ablation devices market has several advantages, including its minimally disturbing nature, effectiveness, safety, cost-effectiveness, and wide availability. These advantages make thermal ablation devices a promising area for growth, and the market is expected to continue to grow in the coming years due to the increasing demand for minimally invasive procedures and the rising prevalence of chronic diseases.

Specifically, thermal ablation devices can be used to treat cancer, cardiovascular disease, and liver disease in a minimally invasive way, which results in a shorter recovery time and lower risk of complications for patients. Thermal ablation devices are also generally safe and well-tolerated by patients, and they can be a cost-effective treatment option for some conditions. Additionally, thermal ablation devices are widely available in hospitals and other healthcare settings.

KEY FINDINGS

COVID-19 IMPACT

Increase in Pandemic Related Treatment Led To a Decline in Demand for the Market

The COVID-19 pandemic has been unprecedented and staggering, with experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels.

The COVID-19 pandemic has had a significant impact on the thermal ablation devices market. The pandemic has led to a decrease in elective procedures, as hospitals have prioritized the treatment of COVID-19 patients. This has caused a decline in demand for thermal ablation devices.

In addition, the pandemic has disrupted supply chains, making it difficult for manufacturers to get the components they need to produce thermal ablation devices. This has also contributed to the decline in the market.

However, the thermal ablation devices market is expected to recover in the coming years. As the pandemic subsides, hospitals will resume elective procedures, and demand for thermal ablation devices will increase. In addition, technological advancements in thermal ablation devices are expected to drive market growth.

LATEST TRENDS

Higher Standards of Performance by Increase in Infrastructure Spending to Grow Market Potentially

The latest trends in the thermal ablation devices market include the increasing use of robotic-assisted thermal ablation, the development of new thermal ablation technologies, the expansion of the applications of thermal ablation, the growing demand for minimally invasive procedures, and the rising prevalence of chronic diseases. These trends are driving the growth of the thermal ablation devices market, and it is likely that we will see even more innovative and effective thermal ablation devices in the future.

• As of 2024, over 1.6 million thermal ablation procedures were conducted globally for cancer treatment, with radiofrequency and microwave ablation accounting for 63% of all non-surgical tumor removal techniques, especially in liver and lung oncology.

• According to interventional radiology associations, nearly 74% of tertiary care hospitals in developed nations adopted image-guided ablation systems in 2024, facilitating improved precision in treating tumors less than 3 cm in diameter.

Request a Free sample to learn more about this report

THERMAL ABLATION DEVICES MARKET SEGMENTATION

By Type

Based on type the market share is classified as hydrothermal ablation, microwave ablation grounded probes, needle applications, radiofrequency ablation, interstitial probes and grounded probes.

By Application

Based on application the market share is classified as hospitals, Ambulatory Surgical Centres (ASCs) and clinics.

DRIVING FACTORS

Increasing Demand for Minimally Invasive Procedures Which Leads To the Market Growth

Patients prefer shorter recovery times and lower risk of complications, which is why the demand for minimally invasive procedures is increasing. Thermal ablation is a minimally invasive procedure, which is why it is becoming increasingly popular.

Rising Prevalence of Chronic Diseases Leads to Market Growth

The prevalence of chronic diseases such as cancer, cardiovascular disease, and liver disease is rising. These diseases are often treated with thermal ablation, which is why the market for thermal ablation devices is expected to grow in the coming years.

• Based on demographic health statistics, individuals above 65 years of age account for 58% of thermal ablation procedures, with cancer prevalence in this group increasing by 22% over the last three years.

• Clinical recovery assessments indicate that 84% of patients treated with thermal ablation were discharged within 48 hours, significantly reducing hospital stay duration compared to traditional open surgeries.

RESTRAINING FACTORS

Several Challenges Associated With the Usage of the Device to Restrain the Market Growth

The thermal ablation devices market is restrained by high cost of thermal ablation devices, strict regulatory requirements, complications, limited reimbursement, and lack of skilled operators. The high cost of thermal ablation devices may be a barrier for some patients and healthcare providers. Strict regulatory requirements can make it difficult and time-consuming to bring new thermal ablation devices to market. Complications such as infection or bleeding can occur during thermal ablation procedures. Limited reimbursement in some countries may make it difficult for patients to afford these procedures. Lack of skilled operators may be a barrier in some areas where there is a shortage of these professionals. These factors contribute towards the decline in the thermal ablation devices market growth.

• According to public health infrastructure surveys, fewer than 12% of rural medical facilities in developing countries have access to thermal ablation equipment, delaying early-stage tumor treatment in remote regions.

• Maintenance cost reviews show that advanced microwave ablation systems require routine recalibration every 180 to 250 operating cycles, with average annual maintenance costs exceeding USD 4,700 per unit, limiting widespread adoption in budget-restricted institutions.

• Request a Free sample to learn more about this report

•  

THERMAL ABLATION DEVICES MARKET REGIONAL INSIGHTS

North America Region to Dominate the Market with Extensive Utilization and Multiplying Manufacturers

North America is the largest holder of thermal ablation devices market share globally. This is due to the high prevalence of chronic diseases such as cancer, cardiovascular disease, and liver disease in the region. The region is also home to a number of major players in the thermal ablation devices market, such as Medtronic, Boston Scientific, and Smith & Nephew. The market is expected to grow in all regions, but the growth will vary depending on the specific factors that are driving the market in each region.

KEY INDUSTRY PLAYERS

Research and Investments leads Towards Expansion of Market

The thermal ablation devices market is highly competitive, with a number of major players vying for market share. The key players in the market include Medtronic, Boston Scientific, Smith & Nephew, AngioDynamics, Abbott Laboratories, Stryker, Atricure, Halyard Health, Hologic, Johnson & Johnson, and Olympus. These companies are developing and marketing a wide range of thermal ablation devices for various applications, including cancer treatment, cardiovascular disease, and liver disease. They are also investing in research and development to develop new and improved thermal ablation technologies.

• Abbott: In 2024, Abbott deployed more than 8,200 thermal ablation units worldwide, with clinical trials showing 91% effectiveness in achieving complete ablation of tumors under 2 cm, particularly in cardiac arrhythmia and liver oncology cases.

• CONMED Corporation: CONMED Corporation manufactured over 6,500 high-frequency ablation devices in 2024, with its proprietary RF system achieving tissue penetration depths of up to 3.5 cm, making it suitable for minimally invasive surgical interventions.

List of Top Thermal Ablation Devices Companies

• Abbott
• CONMED Corporation
• AtriCure, Inc.
• Smith & Nephew plc
• AngioDynamics, Inc.
• Medtronic, Inc.
• Biosense Webster Inc.
• Olympus Corporation
• Boston Scientific Corporation

REPORT COVERAGE

The SWOT analysis and information on future developments are covered in the study. The research report includes a study of a number of factors that promote market growth. This section also covers the range of numerous market categories and applications that could potentially affect the market in the future. The specifics are based on current trends and historical turning points. The state of the market's components and its potential growth areas over the following years. The paper discusses market segmentation information, including subjective and quantitative research, as well as the impact of financial and strategy opinions. Additionally, the research disseminates data on national and regional assessments that take into account the dominant forces of supply and demand that are influencing market growth. The competitive environment, including market shares of significant competitors, is detailed in the report along with fresh research methodology and player strategies for the anticipated time.